End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
8.82
CNY
|
+0.57%
|
|
+3.52%
|
-25.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,730
|
13,010
|
13,274
|
11,866
|
12,111
|
9,007
|
-
|
-
|
Enterprise Value (EV)
1 |
9,730
|
12,118
|
12,237
|
11,312
|
11,980
|
9,055
|
8,879
|
9,238
|
P/E ratio
|
38.1
x
|
30.9
x
|
25.8
x
|
21.5
x
|
30
x
|
18.3
x
|
13.6
x
|
12.3
x
|
Yield
|
0.82%
|
0.98%
|
1.16%
|
1.55%
|
1%
|
2.02%
|
2.42%
|
2.55%
|
Capitalization / Revenue
|
2.36
x
|
2.6
x
|
2.5
x
|
2.01
x
|
2.24
x
|
1.47
x
|
1.28
x
|
1.18
x
|
EV / Revenue
|
2.36
x
|
2.42
x
|
2.31
x
|
1.92
x
|
2.22
x
|
1.48
x
|
1.26
x
|
1.21
x
|
EV / EBITDA
|
19.3
x
|
14
x
|
13.3
x
|
12.7
x
|
17.1
x
|
9.69
x
|
7.62
x
|
7.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.36
x
|
2.9
x
|
2.7
x
|
2.24
x
|
2.19
x
|
1.52
x
|
1.39
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
1,009,951
|
1,015,611
|
1,015,611
|
1,021,148
|
1,021,148
|
1,021,148
|
-
|
-
|
Reference price
2 |
9.634
|
12.81
|
13.07
|
11.62
|
11.86
|
8.820
|
8.820
|
8.820
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,118
|
4,999
|
5,302
|
5,892
|
5,406
|
6,128
|
7,056
|
7,623
|
EBITDA
1 |
505.2
|
864.9
|
920.4
|
890
|
699.2
|
934.5
|
1,165
|
1,266
|
EBIT
1 |
328.9
|
673
|
664.3
|
622.1
|
402.8
|
597.7
|
786.9
|
850.9
|
Operating Margin
|
7.99%
|
13.46%
|
12.53%
|
10.56%
|
7.45%
|
9.75%
|
11.15%
|
11.16%
|
Earnings before Tax (EBT)
1 |
344.1
|
536
|
669.2
|
626.5
|
406.4
|
582.5
|
769
|
859.7
|
Net income
1 |
255.5
|
420.4
|
513.9
|
550.1
|
403.1
|
492.7
|
651.8
|
731.1
|
Net margin
|
6.21%
|
8.41%
|
9.69%
|
9.34%
|
7.46%
|
8.04%
|
9.24%
|
9.59%
|
EPS
2 |
0.2530
|
0.4148
|
0.5060
|
0.5401
|
0.3947
|
0.4814
|
0.6485
|
0.7167
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0792
|
0.1250
|
0.1520
|
0.1800
|
0.1190
|
0.1781
|
0.2135
|
0.2250
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
|
2,597
|
1,529
|
1,766
|
3,295
|
-
|
-
|
1,651
|
1,247
|
2,898
|
-
|
2,662
|
-
|
-
|
3,370
|
3,434
|
3,685
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
314.3
|
-
|
158.5
|
307.8
|
-
|
-
|
136.7
|
-18.09
|
118.6
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
12.1%
|
-
|
8.98%
|
9.34%
|
-
|
-
|
8.28%
|
-1.45%
|
4.09%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
149.6
|
-
|
140.5
|
-
|
128
|
6.094
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
8.47%
|
-
|
-
|
-
|
7.75%
|
0.49%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
0.1400
|
0.1500
|
-
|
0.1376
|
0.2634
|
0.1300
|
0.001300
|
0.1300
|
-
|
0.1300
|
-
|
-
|
0.2100
|
0.2400
|
0.2600
|
Dividend per Share
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2124
|
-
|
-
|
-
|
Announcement Date
|
8/17/22
|
10/28/22
|
4/21/23
|
4/21/23
|
4/28/23
|
8/30/23
|
10/30/23
|
4/9/24
|
4/9/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
48.7
|
-
|
231
|
Net Cash position
1 |
-
|
892
|
1,037
|
553
|
131
|
-
|
128
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.0521
x
|
-
|
0.1827
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.29%
|
9.61%
|
10.8%
|
10.6%
|
7.46%
|
8.41%
|
10.1%
|
9.82%
|
ROA (Net income/ Total Assets)
|
4.08%
|
6.66%
|
7.19%
|
-
|
-
|
5.64%
|
6.5%
|
6.66%
|
Assets
1 |
6,267
|
6,312
|
7,144
|
-
|
-
|
8,736
|
10,031
|
10,977
|
Book Value Per Share
2 |
4.080
|
4.410
|
4.840
|
5.190
|
5.410
|
5.810
|
6.360
|
6.920
|
Cash Flow per Share
2 |
0.0300
|
0.6600
|
0.3800
|
-0.2200
|
0.3600
|
0.6900
|
0.7700
|
0.7600
|
Capex
1 |
424
|
531
|
476
|
426
|
638
|
489
|
463
|
334
|
Capex / Sales
|
10.29%
|
10.63%
|
8.98%
|
7.23%
|
11.81%
|
7.97%
|
6.56%
|
4.38%
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Last Close Price
8.82
CNY Average target price
11.62
CNY Spread / Average Target +31.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.63% | 1.24B | | -15.35% | 76.34B | | -9.19% | 6.67B | | +24.75% | 3.7B | | -1.11% | 3.21B | | +6.08% | 1.52B | | -15.13% | 1.37B | | -7.62% | 1.21B | | -10.84% | 1.17B | | -.--% | 1.05B |
Veterinary Drugs
|